Journal of Clinical Immunology

, Volume 3, Issue 2, pp 178–183 | Cite as

Serum IgE and IgG antibodies to tetanus toxoid and candidin in immunodeficient children with the hyper-IgE syndrome

  • Christian Schmitt
  • Jean Jacques Ballet
Original Articles


Serum IgG and IgE antibodies directed against tetanus toxoid and candidin were measured using a solid-phase radioimmunoassay in seven patients with the immunodeficiency syndrome with hyper-IgE. In parallel, six normal children, three normal adults, and eight patients with or without elevated serum IgE (including atopic diseases,Candida infections, and active schistosomiasis) were studied. Serum IgG antibodies to tetanus toxoid and candidin were present in the hyper-IgE patients in concordance with their immunization history. High concentrations of IgE antibodies against both antigens were found in the immune hyper-IgE patients but not in the controls. This suggests that elevated IgE antibody responses in the hyper-IgE syndrome results from a primary defect of IgE class regulation rather than an abnormal or deficient antibody response.

Key words

Immunodeficiency hyper-IgE syndrome serum antibodies tetanus toxoid candidin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buckley RH, Wray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49:59–70, 1972Google Scholar
  2. 2.
    Clark RA, Root RK, Kimball HR, Kirkpatrick CH: Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med 78:515–519, 1973Google Scholar
  3. 3.
    Hill HR, Quie PG: Raised serum IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1:183–197, 1974Google Scholar
  4. 4.
    Buckley RH, Becker WG: Abnormalities in the regulation of human IgE synthesis. Immunol Rev 41:288–314, 1978Google Scholar
  5. 5.
    Berger M, Kirkpatrick CH, Goldsmith PK, Gallin JI: IgE antibodies toStaphylococcus aureus andCandida albicans in patients with the syndrome of hyper-immunoglobulin E and recurrent infections. J Immunol 125:2437–2443, 1980Google Scholar
  6. 6.
    Schopfer K, Baerlocher K, Price P, Krech U, Quie PG, Douglas SD: Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and staphylococcus aureus infections. N Engl J Med 300:835–838, 1979Google Scholar
  7. 7.
    Church JA, Frenkel LD, Wright DG, Bellanti JA: T lymphocyte dysfunction, hyper-immunoglobulinemia E, recurrent bacterial infection and defective neutrophil chemotaxis in a Negro child. J Pediatr 88:982–985, 1976Google Scholar
  8. 8.
    Gallin JM, Wright DG, Malech HL, Davis JM, Klempner MS, Kirkpatrick CH: Disorders of phagocyte chemotaxis. Ann Intern Med 92:520–525, 1980Google Scholar
  9. 9.
    Buckley RH: Augmented immunoglobulin E synthesis in primary immunodeficiency.In Cellular, Molecular and Clinical Aspect of Allergic Disorders, S Gupta, RA Good (eds). New York, Plenum, 1979, pp 513–535Google Scholar
  10. 10.
    Bizzini B: Tetanus toxin. Microbiol Rev 43:224–240, 1979Google Scholar
  11. 11.
    Zollinger WD, Dalrymple JM, Artenstein MS: Analysis of parameters affecting the solid phase radio immunoassay quantitation of antibody to meningococcal antigens. J Immunol 117:1788–1798, 1976Google Scholar
  12. 12.
    Stevens RH, Saxon A: Reducedin vitro production of antitetanus toxoid antibody after repeatedin vivo immunization with tetanus toxoid. J Immunol 122:592–598, 1979Google Scholar
  13. 13.
    Nagel J, Svec D, Waters T, Fireman P: IgE synthesis in man. I. Development of specific IgE antibodies after immunization with tetanus-diphtheria (TD) toxoids. J Immunol 118:334–341, 1977Google Scholar
  14. 14.
    Mathur S, Goust JM, Horger EO, Fudenberg HH: Immunoglobulin E anti-Candida antibodies and candidiasis. Infect Immun 18:257–260, 1977Google Scholar
  15. 15.
    Ishizaka K, Ishizaka T: Mechanisms of reagininic hypersensitivity and IgE antibody response. Immunol Rev 41:109–148, 1978Google Scholar
  16. 16.
    Jarret EEE: Stimuli for the production and control of IgE in rats. Immunol Rev 41:52–76, 1978Google Scholar
  17. 17.
    Patterson R, Suszko IM, Hsu CCS, Roberts M, Oh SH:In vitro production of IgE by lymphocytes from a patient with hypergammaglobulinemia E, eosinophilial and increased lymphocytes carrying surface IgE. Clin Exp Immunol 20:265–276, 1975Google Scholar
  18. 18.
    Saxon A, Stevens RH: Subpopulations of circulating B-cells and regulating T-cells involved inin vitro IgE production in atopic patients with elevated serum IgE. J Clin Invest 65:1457–1468, 1980Google Scholar
  19. 19.
    Sampson HA, Buckley RH: Human IgE synthesisin vitro: A reassessment. J Immunol 127:829–834, 1981Google Scholar
  20. 20.
    Romagnani S, Maggi GF, Delprete F, Maggi E, Bargellesi A, Ricci M:In vitro production of IgE by human peripheral blood mononuclear cells. III. Demonstration of circulating IgE bearing cells involved in the spontaneous IgE synthesis. Clin Exp Immunol 49:176–184, 1982Google Scholar
  21. 21.
    Gupta S: Subpopulation of human T lymphocytes. XVIII. T lymphocytes with receptors for IgE (T epsilon) in patients with primary immunodeficiency and hyperimmunoglobulinemia E states. Clin Exp Immunol 45:113–117, 1981Google Scholar

Copyright information

© Plenum Publishing Corporation 1983

Authors and Affiliations

  • Christian Schmitt
    • 1
    • 2
    • 3
  • Jean Jacques Ballet
    • 1
    • 2
    • 3
  1. 1.Laboratoire d'Immunochimie et d'Immunopathologie (INSERM U108)Université Paris VIIParisFrance
  2. 2.Institut de Recherches sur les Maladies du SangUniversité Paris VIIParisFrance
  3. 3.Laboratoire d'Oncologie et d'Immunohematologie du CNRSHôpital Saint-LouisParisFrance

Personalised recommendations